Envoy Medical, Inc. (COCH): auditor change — Envoy Medical dismisses Grant Thornton, appoints EisnerAmper as auditor for FY2026

Envoy Medical, Inc.

Grant Thornton dismissed effective March 25, 2026; EisnerAmper appointed for year ending Dec 31, 2026.
Grant Thornton's reports for 2024 and 2025 included a going concern explanatory paragraph.
No disagreements with Grant Thornton; prior material weaknesses in internal controls reported.
Engagement agreement with EisnerAmper dated March 26, 2026; no pre-approval consultations occurred.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Envoy Medical, Inc. engaged EisnerAmper LLP as its auditor.

Action: engagement
Auditor: EisnerAmper LLP

Exact text from the filing

Upon the approval of the Committee, the Company entered into an engagement agreement with EisnerAmper, dated March 26, 2026, to serve as the Company’s independent public accounting firm for the fiscal year ending December 31, 2026.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Envoy Medical, Inc. dismissed Grant Thornton LLP as its auditor.

Action: dismissal
Auditor: Grant Thornton LLP
Successor: EisnerAmper LLP

Exact text from the filing

On March 25, 2026, the Company notified Grant Thornton LLP (“ Grant Thornton ”) of its dismissal as the Company’s independent registered public accounting firm, effective as of the date of the notice.

View on SEC.gov

6 auditor changes filed in the last 30 days. Browse all auditor changes →

Envoy Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-037419

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.